Pharmacoeconomic evaluation of different modes of enzyme substitution therapy in Russian patients with exocrine pancreatic insufficiency

The abstract is a clinical and economic analysis of the treatment of exocrine pancreatic insufficiency ratedetermining drugs: Mezim Forte, Mezim Forte 10 000 and Mezim 20 00 using pharmacoeconomic models for estimating the costs of drug therapy in different strategies of enzyme replacement therapies assess whether the costs of health budgets at different levels.